Stock Information
Charles River Laboratories International, Inc. (CRL)
Ticker Symbol: CRL
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $16,134.31 mil
Piotroski score: 6
PE Ratio: 375.16
EPS (TTM): 0.90
Revenue (TTM): $81.86 M
Dividend Yield: N/A
ROE: 1.32%
Latest News
-
Charles River Stock Surges 102.3% in a Year: What's Fueling the Drive?
Fri, Nov 20, 2026 4:57 PM
-
Oncology Based in-Vivo CRO - Global Strategic Business Report 2026: Capitalize on the $1.7 Billion 2032 Market with Charles River, Crown Bioscience, Wuxi AppTec and Eurofins
Fri, Nov 20, 2026 3:01 PM
-
Invesco S&P 500 Equal Weight (RSP) Buys $0.6 Million More AppLovin on Nov. 17
Thu, Nov 19, 2026 11:05 AM
-
Global Preclinical CRO Services Market Opportunities and Strategies to 2035 | Capitalize on AI, Oncology and Biomarkers with Charles River, WuXi AppTec, Eurofins and Pharmaron
Wed, Nov 18, 2026 2:37 PM
-
Charles River Laboratories International (CRL) Recovers Following Cyclical Contraction
Wed, Nov 18, 2026 2:01 PM
-
Should You Continue to Hold Charles River Stock in Your Portfolio?
Wed, Nov 18, 2026 1:47 PM
-
Tracking John Rogers' Ariel Investments Portfolio - Q3 2026 Update
Wed, Nov 18, 2026 12:07 PM
-
A $2.4 Billion Fund Dumps These 3 Stocks
Tue, Nov 17, 2026 7:05 PM
-
Charles River Laboratories International (CRL) Opens Dublin Site and South Korea Depot
Tue, Nov 17, 2026 5:16 PM
-
Charles River Laboratories (CRL) Stock Looks Fairly Valued Despite Its 106% Run
Tue, Nov 17, 2026 4:11 PM
Key Financials
Financial data not available